Certified by Founder Lodge
SANTÉ
United States - Austin, Texas
INVESTOR
1 Disclosed Funding Rounds $6,000,000
37 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Santé invests at the leading edge of innovation in Healthcare and Technology. We manage over a half-billion dollars of capital invested in two separate strategies.
Santé Ventures invests
| Company | Date | Round | Raised |
|---|---|---|---|
 Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
 Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
 Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
 Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
| Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
 Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
| Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
 Wave |
March, 08 ,2023 | Seed | $6,000,000 |
| Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
 Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
| Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
| Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
| Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
| Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
 ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
| Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
| Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
| Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
| Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
 OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
| Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
| Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
| Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
| Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
| ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
| ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
| Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
| OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
| OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
 Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
| Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
 AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
| Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
| ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
| OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
| Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
| AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Valinor | $13,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)
